Infection and Systemic Sclerosis

Infection and Autoimmunity, 2nd edition

Volumn , Issue , 2004, Pages 613-622

  Guiducci, Serena ^a   Giacomelli, Roberto ^b   Tyndall, A ^c   Cerinic, Marco Matucci ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 32644475819     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044451271-0.50047-8     Document Type: Chapter

References (86)

1. Medsger TA Systemic Sclerosis, localized forms of scleroderma, and calcinosis. Arthritis and Allied Conditions 1992, 1253-1292. Les & Febiger, Philadelphia. 12th Ed. D.J. McCarty (Ed.).
2. White B Immunopathogenesis of Systemic Sclerosis. Rheum Dis Clin North Am 1996, 22:695-708.
3. Vaughan JH, Shaw PX, Nguyen MD, Medsger TA, Wright TM, Metcalf JS, LeRoy EC Evidence of activation of 2 herpesvirus, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins. J Rheumatol 2000, 27:821-823.
4. Henry PA, Atamas SP, Yurovsky VV, Luzina I, Wigley FM, White B Diversity and plasticity of the anti-DNA topoisomerase I utoantibody response in scleroderma. Arthritis Rheum 2000, 43:2733-2742.
5. Vaughan JH Viruses and autoimmune disease. J Rheumatol 1996, 23:1831-1833.
6. Lunardi C, Bason C, Navone R, Millo E, Damonte G, Corrocher R, Puccetti A Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nature Medicine 2000, 6:1183-1186.
7. Ferri C, Zakrzewska K, Longombardo G, Giuggioli D, Storino FAA, Pasero G, Azzi A Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol 1999, 17:718-720.
8. Ferri C, Cazzato M, Giuggioli M, Sebastiani M, Magro C Systemic sclerosis following human cytomegalovirus infection. Ann Rheum Dis 2002, 61:937-938.
9. Ferri C, Zakrzewska K, Giuggioli D, Longobardo G, Sebastiani M, Storino F Parvovirus B19 infection in the skin and bone marrow of systemic sclerosis patients. Arthrtitis Rheum 2000, 43:315.
10. Lehmann HW, Kuhner L, Beckenlehner K, Muller-Godeffroy E, Heide KG, Kuster RM, Modrow S Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence. J Clin Virology 2002, 25:135-143.
11. Naides SJ Rheumatic manifestations of parvovirus B19 infection. Rheum Dis Clin North Am 1998, 24:375-401.
12. Yoto Y, Kudoh T, Haseyama K, Suzuki N, Oda T, Katoh T, Takahashi T, Sekiguchi S, Chiba S Incidence of human parvovirus B19 DNA detection in blood donors. Br J Haematol 1995, 91:1017-1018.
13. Ferri C, Longobardo G, Azzi A, Zakrzewska K Parvovirus B19 and systemic sclerosis. Clin Exp Rheumatol 1999, 17:267.
14. Cassinotti P, Burtonoboy G, Fopp M, Siegl G Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 1997, 53:229-232.
15. Ferri C, Giuggioli D, Sebastiani M, Panfilo S, Abatangelo G, Zakrzewska K, Azzi A Parvovirus B19 infection of cultured skin fibroblasts from systemic sclerosis patients: comment on the artiche by Ray et al. Arthritis Rheum 2002, 46:2262-2263.
16. Ray NB, Nieva DRC, Seftor EA, Khalkhali-Ellis Z, Naides SJ Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts. Arthritis Rheum 2001, 44:1582-1586.
17. Kerr JR Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis 2000, 59:672-683.
18. Chizzolini C, Raschi E, Rezzonico R, Testoni C, Melloni R, Gabrielli A Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum 2002, 46:602-1613.
19. Pandey JP, LeRoy EC Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis. Arthritis Rheum 1998, 41:10-15.
20. Vaughan JH, Smith EA, LeRoy EC, Arnett FC, Wright TA, Medsger TA An autoantibody in systemic scleroderma that reacts with glycine rich sequences. Arthritis Rheum 1995, 38:S255.
21. Zhou YF, Shou M, Harrell RF, Yu ZX, Unger EF, Epstein SE Chronic non-vascular cytomegalovirus infection: effects on the neointimal response to experimental vascular injury. Cardiovasc Res. 2000 Mar., 45(4):1019-1025.
22. Presti RM, Pollock JL, Dal Canto AJ, O'Guin AK, Virgin HW 4th Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med 1998, 188(3):577-588.
23. Shahgasempour S, Woodroffe SB, Sullivan-Tailyour G, Garnet HM Alteration in the expression of endothelial cell integrin receptors alpha5beta1 and alpha2beta1 and alpha6beta1 after in vitro infection with a clinical isolate of human cytomegalovirus. Arch Virol 1997, 142:125-138.
24. Wing BA, Lee GCY, Huang E The human cytomegalovirus UL94 open reading frame encodes a conserved herpesvirus capsid/tegument-associated virion protein that is expressed with true late kinetics. J Virol 1996, 70:3339-3345.
25. Tachibana I, Bodorova J, Berditchevski F, Zutter MM, Helmer ME NAG-2, a novel transmembrane-4 superfamily (TM4SF) protein that complexes with integrins and other TM4SF proteins. J Biol Chem 1997, 272:29181-29189.
26. Muryoi T, Kasturi KN, Kafina MJ, Cram DS, Harrisson LS, Sasaki T, Bona CA Antitopoisomerase I monoclonal autoantibodies from scleroderma patients and tight skin mouse interact with similar epitopes. J Exp Med 1992, 175:1103-1109.
27. Neidhart M, Kuchen S, Distler O, Bruhlmann P, Michel BA, Gay RE, Gay S Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis. Arthritis Rheum 1999, 42:389-392.
28. Tsukamoto K, Hayakawa H, Sato A, Chida K, Nakamura H, Miura K Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis. Thorax 2000, 55:958-961.
29. Rhodes GH, Valbracht JR, Nguyen MD, Vaughan JH The p542 gene encodes an autoantigen that cross reacts with EBNA-1 of the Epstein-Barr virus and which may be a heterogeneous nuclear ribonucleoprotein. J Autoimmun 1997, 10:447-454.
30. Vaughan JH, Valbracht JR, Nguyen MD, Patrick K, Rhodes GH Epstein-Barr virus-induced autoimmune responses. I. IgM autoantibodies to proteins mimicking and not mimicking EBNA-1. J Clin Invest 1995, 95:1306-1315.
31. Vaughan JH, Nguyen MD, Valbrach JR, Patrick K, Rhodes GH Epstein-Barr virus-induced autoimmune responses. I. IgG autoantibodies to mimicking and not mimicking epitopes. Presence in autoimmune disease. J Clin Invest 1995, 95:1316-1327.
32. Wright DA, Staprans SI, Spector DH Four phosphoproteins with common amino termini are encoded by human cytomegalovirus AD169. J Virol 1988, 62:331-340.
33. Staprans SI, Spector DH 2.2-kilobase class or early transcripts encoded by cell-related sequences in human cytomegalovirus strain AD169. J Virol 1986, 57:591.
34. Krieg AM, Gourley MF, Perl A Endogenous retroviruses: potential etiologic agents in autoimmunity. FASEB J 1992, 6:2537-2544.
35. Dang H, Dauphinée MJ, Talal N Serum antibody to retroviral gag proteins in systemic sclerosis. Arthritis Rheum 1991, 34:1336-1337.
36. Maul GG, Jemenez SA, Riggs E, Ziemericka-Kotula D Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase-I: sequence similarty with retroviral p30 gag protein suggests a possible cause for autoimmunity in systemic sclerosis. Proc Natl Acad Sci USA 1989, 86:8492-8496.
37. Haustein UF, Pustowoit B, Krusche U, Herrmann K Antibodies to retrovirus proteins in scleroderma. Acta Dermatol Venereol 1993, 73:116-118.
38. Perl A, Banki K Molecular mimicry, altered apoptosis, and immunomodulation as mechanisms of viral pathogenesis in systemic lupus erythematosus. Lupus: molecular and cellular pathogenesis 1999, 43-64. Humana Press, Totowa, NJ. G.M. Kammer, G.C. Tsokos (Eds.).
39. Brookes SM, Pandolfino YA, Mitchell TY, Venables PJ, Shattles WG, Clark DA, Entwistle A, Maini RN The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br J Rheumatol 1992, 31:735-742.
40. Perl A, Colombo E, Dai H, Agarwal R, Mark KA, Banki K, Poiesz BJ, Phillips PE, Hoch SO, Reveille JD Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes: correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum 1995, 38:1660-1671.
41. Bengtsson A, Blomberg J, Nived O, Pipkorn R, Toth L, Sturfelt G Selective antibody reactivity with peptides from human endogenous retroviruses and nonviral polyamino acids in patients with systemic lupus erythematosus. Arthritis Rheum 1996, 39:1654-1663.
42. Oldstone MBA Molecular mimicry and autoimmune disease. Cell 1987, 50:819-820.
43. Query CC, Keene JD A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. Cell 1987, 51:211-220.
44. Maul GG, Jimenez SA, Riggs E, Ziemnicka-Kotula D Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in systemic sclerosis. Proc Natl Acad Sci USA 1989, 86:8492-8496.
45. Banki K, Maceda J, Hurley E, Ablonczy E, Mattson DH, Szegedy L, Hung C, Perl A Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-I gag-reactive autoantibodies. Proc Natl Acad Sci USA 1992, 89:1939-1943.
46. Fujinami RS, Oldstone MBA, Wroblewska Z, Frankel ME, Koprowski H Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci USA 1983, 80:2346-2350.
47. Perl A, Isaacs C, Eddy RL, Byers MG, Shows TB The human T-cell leukemia virus-related endogenous sequence (HRES1) is located on chromosome 1 at q42. Genomics 1991, 11:1172-1173.
48. Emerit J Chromosomal instability in collagen disease. Z Rheumatol 1980, 39:84-90.
49. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC Relation of Helicobacter Pylori infection and coronary heart disease. Br Heart J 1994, 71:437-439.
50. Reinauer S, Goerz G, Ruzicka T, Susanto F, Humfeld S, Reinauer H Helicobacter pylori in patients with systemic sclerosis, detection with the 13-urea breath test and eradication. Acta Derm-Venereol 1994, 74:361-363.
51. Fojimoto M, Sato S, Ihn H, Takehara K Autoantibodies to the heat-shock protein hsp73 in localized scleroderma. Arch Dermal Res 1995, 287:581-585.
52. Showji Y, Nozawa R, Sato K, Suzuki H Seroprevalence of Helicobacter pylori infection in patients with connective tissue diseases. Microbiol Immunol 1996, 40:499-503.
53. Yazawa N, Fujimoto M, Kikuchi K, Kubo M, Ihn H, Sato S, Tamaki T, Tamaki K High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with oesophageal involvement. J Rheumatol 1998, 4:650-653.
54. Macchia G, Massone A, Burroni D, Covacci A, Censini S, Rappuoli R The hsp60 protein of Helicobacter pilori: structure and immune response in patients with gastroduodenal diseases. Mol Microbiol 1993, 3:645-652.
55. Winfield JB, Jarjour W Do stress proteins play a role in arthritis and autoimmunity?. Immunol Rev 1991, 121:193-220.
56. Yamaguchi H, Osaki T, Kai M, Taguchi H, Kamiya S Immune response against a cross-reactive epitope on the heat shock protein 60 homologue of Helicobacter pylori. Infect Immun 2000, 68:3448-3454.
57. Kalabay L, Fekete B, Czirjàk L, Horvàth L, Daha MR, Veres A, Fònyad G, Horvàth A, Vicziàn A, Singh M, Hoffer I, Fust G, Romics L, Prohàszka Z Helicobacter Pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter 2002, 7:250-258.
58. Gasbarrini A, Serricchio M, Tondi P, Gasbarrini G, Pola P Association of Helicobacter Pylori infection with primary Raynaud's phenomenon. Lancet 1996, II:966-967.
59. Gasbarrini A, Massari I, Serricchio M, Tondi P, De Luca A, Franceschi F, Ojetti V, Dal Lago A, Flore R, Santoliquido A, Gasbarrini G, Pola P Helicobacter pilori eradication ameliorates primary Raynaud's phenomenon. Dig Dis Sci 1998, 43:1641-1645.
60. Panoutsakopoulou V, Sanchirico ME, Huster KM, Jansson M, Granucci F, Shim DJ, Wucherpfennig KW, Cantor H Analysis of the relationship between viral infection and autoimmune disease. Immunity 2001, 15(1):137-147.
61. Hemmer B, Fleckenstein BT, Vergelli M, Jung G, McFarland H, Martin R, Wiesmuller KH Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med 1997, 185(9):1651-1659.
62. Ohashi PS, Oehen S, Buerki K, Pircher H, Ohashi CT, Odermatt B, Malissen B, Zinkernagel RM, Hengartner H Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991, 65:305-317.
63. Wucherpfennig KW, Strominger JL Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995, 80(5):695-705.
64. Bordron A, Dueymes M, Levy Y, Jamin C, Leroy JP, Piette JC, Shoenfeld Y, Youinou PY The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest 1998, 101:2029-2035.
65. Carvalho D, Savage OS, Black CM, Pearson JD IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. J Clin Invest 1996, 97:111-119.
66. Di Rosa F, Barnaba V Persisting viruses and chronic inflammation: understanding their relation to autoimmunity. Immunol Rev 1998, 164:17-27.
67. Wucherpfenning KW, Strominger JL Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995, 80:695-705.
68. Zhao SZ, Granucci F, Yeh I, Schaffer PA, Canto H Molecular mimicry by herpes symplex virus-type 1: autoimmune disease after viral infection. Science 1998, 279:1344-1347.
69. LeRoy EC, Systemic Sclerosis A vascular perspective. Rheum Dis Clin North Am 1996, 22:675-694.
70. Kefalides NA response of human vascular cells to viral infection. Endothelial Cell Dysfunction 1992, Plenum Press, New York. N. Simionescu, M. Simionescu (Eds.).
71. Sergent JS Vasculitides associated with viral infections. Clin Rheum Dis 1980, 6:339-350.
72. Hamamdzic DVM, Kasman LM, LeRoy C Role of infectious agents in the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 2002, 14:694-698.
73. Lobo-Yeo A, Lamb JR Superantigens as immunogens and tolerongens. Clin Exp Rheumatol 1993, 11:S17-S21.
74. Friedman SM, Posnett DN, Tumang JR, Cole BC, Crow MK A potential role for microbial superantigens in the pathogenesis of autoimmune diseases. Arthritis Rheum 1991, 34:468-480.
75. Nelson JL Microchimerism in human health and disease. Autoimmunity 2003, 36:5-9.
76. Arlett CM, Cox LA, Jimenez SA Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens. Arthritis Rheum 2000, 43:1062-1067.
77. Burastero SE, Galbiati S, Vassallo A, Sabbadini MG, Bellone M, Marchionni L, Smid M, Ferrero E, Ferrari A, Ferrari M, Cremonesi L Cellular microchimersim as a lifelong physiologic status in parous women: an immunologic basis for its amplification in patients with systemic sclerosis. Arthritis Rheum. 2003, 48:1109-1116.
78. Gannage M, Amoura Z, Lantz O, Piette JC, Caillat-Zucman S Feto-maternal microchimerism in connective tissue diseases. Eur J Immunol. 2002, 32:3405-3413.
79. Artlett CM, Cox LA, Ramos RC, Dennis TN, Fortunato RA, Hummers LK, Jimenez SA, Smith JB Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosis. Clin Immunol. 2002, 103:303-308.
80. Artlett CM, Smith JB, Jimenez SA Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Eng J Med 1998, 338:1186-1191.
81. Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, Smith A, Bean MA, Ober C, Bianchi DW Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998, 351:559-562.
82. Waldman WJ Cytomegalovirus as a perturbing factor in graft/host equilibrium: havoc at the endothelial interface. Monographs in Virology 1998, Volume 21:54-66. Karger, Basel. M. Scholz, H.F. Rabenau, H.W. Doerr (Eds.).
83. Waldman WJ, Knight DA, Huang EH An in vitro model of T cell activation by autologous cytomegalovirus (CMV)-infected human adult endothelial cells: contribution of CMV-enhanced endothelial ICAM-1. J Immunol. 1998, 160:3143-3151.
84. Waldman WJ, Adams PW, Orosz CG, Sedmak DD T lymphocyte activation by cytomegalovirus-infected, allogeneic cultured human endothelial cells. Transplantation. 1992, 54:887-896.
85. Giacomelli R, Matucci-Cerinic M, Cipriani P, Ghersetich I, Lattanzio R, Pavan A, Pignone A, Cagnoni ML, Lotti T, Tonietti G Circulating V delta1+T cells are activated and accumulate in the skin of systemic sclerosis patients. Arthritis Rheum 1998, 41(2):327-334.
86. Giacomelli R, Cipriani P, Fulminis A, Nelson L, Matucci Cerinic M. γ/δ T cells in placenta and skin: their different functions may support the paradigm of microchimerism in systemic sclerosis. Clin Exp Rheumatol, in press.